{
  "id": "cluster_15_doc5",
  "content": "Northern California food allergy support groups report confusion about updated Sunrise Network coverage policies. For sublingual therapy under TX815 coding, members cite inconsistent approval timelines ranging 8-28 days. Activist parents circulated guide to navigating exception processes through Mountain View research office, particularly for dual-phase immunotherapy cases with documented migraine comorbidities.",
  "metadata": {
    "format": "patient_survey"
  }
}